David A. Siegel Charles River Laboratories International, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 21,400 shares of CRL stock, worth $4.22 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,400
Previous 24,200
11.57%
Holding current value
$4.22 Million
Previous $6.56 Million
32.58%
% of portfolio
0.01%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$411 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$376 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$270 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...